Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-7-3
pubmed:abstractText
The tumour necrosis factor (TNF)-2 promoter allele, which elicits elevated expression of TNF-alpha, is in linkage disequilibrium with the extended haplotype HLA-A1-B8-DR3-DQ2. TNF-2 and HLA-DR3 have been implicated in renal and cardiac graft rejection and loss. Cytomegalovirus (CMV) infection has been associated with chronic allograft rejection. We examined the relationship between HLA-DR3, promoter allele TNF-2 and cytomegalovirus in relation to chronic rejection following liver transplantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0168-8278
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
711-5
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:11434617-Adolescent, pubmed-meshheading:11434617-Adult, pubmed-meshheading:11434617-Aged, pubmed-meshheading:11434617-Alleles, pubmed-meshheading:11434617-Chronic Disease, pubmed-meshheading:11434617-Cytomegalovirus Infections, pubmed-meshheading:11434617-Female, pubmed-meshheading:11434617-Genetic Linkage, pubmed-meshheading:11434617-Graft Rejection, pubmed-meshheading:11434617-HLA-DR3 Antigen, pubmed-meshheading:11434617-Humans, pubmed-meshheading:11434617-Liver Transplantation, pubmed-meshheading:11434617-Male, pubmed-meshheading:11434617-Middle Aged, pubmed-meshheading:11434617-Promoter Regions, Genetic, pubmed-meshheading:11434617-Prospective Studies, pubmed-meshheading:11434617-Retrospective Studies, pubmed-meshheading:11434617-Risk Factors, pubmed-meshheading:11434617-Tumor Necrosis Factor-alpha
pubmed:year
2001
pubmed:articleTitle
Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts.
pubmed:affiliation
Department of Medicine, University School of Clinical Medicine, Addenbrooke's NHS Trust, Cambridge, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't